Gene · 382
Papers3,632
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,632
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeted inhibition of tumor-derived exosomes as a novel therapeutic option for cancer. | Exp Mol Med | 2022 | 36117219 | PubTator, text mining | PubMed |
| Clinicopathological Implications of ASAP1 Expression in Hepatocellular Carcinoma. | Pathol Oncol Res | 2022 | 36110251 | PubTator, text mining | PubMed |
| Tuberculosis infection related hemophagocytic lymphohistiocytosis diagnosed in patient with GZMB mutation: A case report and literature review. | Medicine (Baltimore) | 2022 | 36107603 | PubTator, text mining | PubMed |
| Abstracts of the XL Congress of the Spanish Society of Physiological Sciences (SECF). | J Physiol Biochem | 2022 | 36107382 | PubTator, text mining | PubMed |
| Radiation induces ESCRT pathway dependent CD44v3+ extracellular vesicle production stimulating pro-tumor fibroblast activity in breast cancer. | Front Oncol | 2022 | 36106109 | PubTator, text mining | PubMed |
| Impaired Autophagy Response in Hepatocellular Carcinomas Enriches Glypican-3 in Exosomes, Not in the Microvesicles. | J Hepatocell Carcinoma | 2022 | 36105695 | PubTator, text mining | PubMed |
| Multiple Roles of SIRT2 in Regulating Physiological and Pathological Signal Transduction. | Genet Res (Camb) | 2022 | 36101744 | PubTator, text mining | PubMed |
| Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential. | Mol Cancer | 2022 | 36100944 | PubTator, text mining | PubMed |
| Tissue factor in cancer-associated thromboembolism: possible mechanisms and clinical applications. | Br J Cancer | 2022 | 36097177 | PubTator, text mining | PubMed |
| Functions and clinical applications of exosomes in pancreatic cancer. | Mol Biol Rep | 2022 | 36097109 | PubTator, text mining | PubMed |
| TurboID Screening of the OmpP2 Protein Reveals Host Proteins Involved in Recognition and Phagocytosis of Glaesserella parasuis by iPAM Cells. | Microbiol Spectr | 2022 | 36094311 | PubTator, text mining | PubMed |
Structural and functional analysis of the small GTPase ARF1 reveals a pivotal role of its GTP-binding domain in controlling of the generation of viral inclusion bodies and replication of grass carp reovirus. | Front Immunol | 2022 | 36091067 | PubTator, text mining | PubMed |
| Extracellular Vesicles Derived from Mesenchymal Stem Cells: A Potential Biodrug for Acute Respiratory Distress Syndrome Treatment. | BioDrugs | 2022 | 36087245 | PubTator, text mining | PubMed |
| Emerging concepts in cancer therapy: Mechanisms of resistance. | Cancer Rep (Hoboken) | 2022 | 36083019 | PubTator, text mining | PubMed |
| Host Cell Signatures of the Envelopment Site within Beta-Herpes Virions. | Int J Mol Sci | 2022 | 36077391 | PubTator, text mining | PubMed |
| The potential applications of microparticles in the diagnosis, treatment, and prognosis of lung cancer. | J Transl Med | 2022 | 36064415 | PubTator, text mining | PubMed |
| Delineating the role of extracellular vesicles in cancer metastasis: A comprehensive review. | Front Immunol | 2022 | 36059497 | PubTator, text mining | PubMed |
| Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma. | Comput Struct Biotechnol J | 2022 | 36051873 | PubTator, text mining | PubMed |
| Rab GTPases: The principal players in crafting the regulatory landscape of endosomal trafficking. | Comput Struct Biotechnol J | 2022 | 36051867 | PubTator, text mining | PubMed |
| The Role and Therapeutic Potential of Macropinocytosis in Cancer. | Front Pharmacol | 2022 | 36046825 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/382/papers?page=31